Compare SWZ & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SWZ | ELV |
|---|---|---|
| Founded | 1986 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.6M | 76.8B |
| IPO Year | N/A | N/A |
| Metric | SWZ | ELV |
|---|---|---|
| Price | $6.11 | $344.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $386.59 |
| AVG Volume (30 Days) | 14.2K | ★ 2.0M |
| Earning Date | 01-01-0001 | 01-28-2026 |
| Dividend Yield | ★ 6.59% | 2.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 25.21 |
| Revenue | N/A | ★ $199,126,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.95 |
| P/E Ratio | ★ N/A | $13.33 |
| Revenue Growth | N/A | ★ 12.62 |
| 52 Week Low | $7.12 | $273.71 |
| 52 Week High | $8.57 | $458.75 |
| Indicator | SWZ | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | 48.24 |
| Support Level | $6.00 | $323.30 |
| Resistance Level | $6.10 | $344.76 |
| Average True Range (ATR) | 0.06 | 14.00 |
| MACD | 0.01 | -1.16 |
| Stochastic Oscillator | 64.29 | 72.23 |
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.